Citadel Advisors’s Sight Sciences SGHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$510K Sell
135,303
-12,535
-8% -$67.6K ﹤0.01% 9255
2025
Q4
$1.17M Buy
+147,838
New +$944K ﹤0.01% 7043
2025
Q3
Sell
-82,163
Closed -$339K 13959
2025
Q2
$339K Sell
82,163
-138,795
-63% -$463K ﹤0.01% 9522
2025
Q1
$530K Sell
220,958
-30,190
-12% -$85K ﹤0.01% 8348
2024
Q4
$914K Buy
251,148
+136,448
+119% +$621K ﹤0.01% 7224
2024
Q3
$723K Buy
114,700
+14,938
+15% +$101K ﹤0.01% 7484
2024
Q2
$665K Buy
99,762
+82,680
+484% +$489K ﹤0.01% 7449
2024
Q1
$90.2K Buy
+17,082
New +$80.3K ﹤0.01% 11495
2023
Q2
Sell
-36,732
Closed -$321K 15123
2023
Q1
$321K Buy
36,732
+36,634
+37,382% +$407K ﹤0.01% 9241
2022
Q4
$1.2K Sell
98
-24,649
-100% -$234K ﹤0.01% 14514
2022
Q3
$157K Buy
+24,747
New +$209K ﹤0.01% 10659
2022
Q2
Sell
-209,789
Closed -$2.42M 13978
2022
Q1
$2.42M Sell
209,789
-59,471
-22% -$915K ﹤0.01% 5670
2021
Q4
$4.73M Buy
269,260
+211,915
+370% +$4.65M ﹤0.01% 4388
2021
Q3
$1.3M Buy
+57,345
New +$1.89M ﹤0.01% 7453

Other funds holding SGHT

Citadel Advisors's SGHT Position: Q1 2026 in Review

Citadel Advisors reduced its Sight Sciences (SGHT) stake by 8.5% in Q1 2026, selling an estimated $67.6K and leaving 135,303 shares worth $510K. The position accounts for ﹤0.01% of the portfolio, ranked #9255.

Citadel Advisors first reported a position in SGHT in Q3 2021 and has held it in 14 quarters since. The position peaked at $4.73M in Q4 2021. 114 funds tracked by Wall St. Rank hold SGHT as of Q1 2026.

  • Citadel Advisors held 135,303 shares of Sight Sciences worth $510K as of Q1 2026.
  • Citadel Advisors sold 12,535 Sight Sciences shares in Q1 2026, an estimated $67.6K.
  • Sight Sciences made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #9255 holding.
  • Citadel Advisors first reported a position in Sight Sciences in Q3 2021 and has held it in 14 quarters since.
  • Citadel Advisors's Sight Sciences position peaked at $4.73M in Q4 2021.
  • 114 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.